ArticleFuture oncology (London, England)2024

Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide.

Benjamin H Lowentritt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.